Transforming growth factor-β activates c-Myc to promote palatal growth

Journal of Cellular Biochemistry

Volumn 113, Issue 10, 2012, Pages 3069-3085

  Zhu, Xiujuan ^a,b   Ozturk, Ferhat ^a   Liu, Changchih ^a   Oakley, Gregory G ^a   Nawshad, Ali ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

c Myc; human embryonic palatal mesenchyme; proliferation; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; SMAD PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL PROLIFERATION; CLEFT PALATE; CONTROLLED STUDY; EMBRYONIC AND PLACENTAL STRUCTURES; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GROWTH; HUMAN; HUMAN CELL; MESENCHYME CELL; ONCOGENE C MYC; PALATE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MESODERM; MICE; MICE, TRANSGENIC; PALATE; PREGNANCY; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84865014029     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24184     Document Type: Article

References (69)

1. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL,. 1997. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272: 27678-27685.
2. Ahmed S, Liu CC, Nawshad A,. 2007. Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3. Dev Biol 309: 193-207.
3. Axmann A, Seidel D, Reimann T, Hempel U, Wenzel KW,. 1998. Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun 249: 456-460.
4. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL,. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810.
5. Bashir T, Horlein R, Rommelaere J, Willwand K,. 2000. Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: A parvovirus DNA replication model. Proc Natl Acad Sci USA 97: 5522-5527.
6. Bierie B, Moses HL,. 2006. Tumour microenvironment: TGFbeta: The molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520.
7. Bodart JF,. 2010. Extracellular-regulated kinase-mitogen-activated protein kinase cascade: Unsolved issues. J Cell Biochem 109: 850-857.
8. Borkowski TA, Letterio JJ, Farr AG, Udey MC,. 1996. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184: 2417-2422.
9. Burdett DN, Waterfield JD, Shah RM,. 1988. Vertical development of the secondary palate in hamster embryos following exposure to 6-mercaptopurine. Teratology 37: 591-597.
10. Carette MJ, Ferguson MW,. 1992. The fate of medial edge epithelial cells during palatal fusion in vitro: An analysis by DiI labelling and confocal microscopy. Development 114: 379-388.
11. Chai Y, Maxson RE, Jr., 2006. Recent advances in craniofacial morphogenesis. Dev Dyn 235: 2353-2375.
12. Cui XM, Warburton D, Zhao J, Crowe DL, Shuler CF,. 1998. Immunohistochemical localization of TGF-beta type II receptor and TGF-beta3 during palatogenesis in vivo and in vitro. Int J Dev Biol 42: 817-820.
13. Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P, Shuler CF,. 2003. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion. Dev Dyn 227: 387-394.
14. Dunker N, Krieglstein K,. 2000. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem 267: 6982-6988.
15. Eisenman RN,. 2001. Deconstructing myc. Genes Dev 15: 2023-2030.
16. Feng XH, Liang YY, Liang M, Zhai W, Lin X,. 2002. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 9: 133-143.
17. Fitzpatrick DR, Denhez F, Kondaiah P, Akhurst RJ,. 1990. Differential expression of TGF beta isoforms in murine palatogenesis. Development 109: 585-595.
18. Foitzik K, Lindner G, Mueller-Roever S, Maurer M, Botchkareva N, Botchkarev V, Handjiski B, Metz M, Hibino T, Soma T, Dotto GP, Paus R,. 2000. Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J 14: 752-760.
19. Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF,. 2004. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 24: 2546-2559.
20. Frey RS, Mulder KM,. 1997. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett 117: 41-50.
21. Gehris AL, D'Angelo M, Greene RM,. 1991. Immunodetection of the transforming growth factors beta 1 and beta 2 in the developing murine palate. Int J Dev Biol 35: 17-24.
22. Gehris AL, Pisano MM, Nugent P, Greene RM,. 1994. Regulation of TGF beta 3 gene expression in embryonic palatal tissue. In Vitro Cell Dev Biol Anim 30A: 671-679.
23. Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH,. 1998. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 23: 87-93.
24. Goldberg PL, MacNaughton DE, Clements RT, Minnear FL, Vincent PA,. 2002. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282: L146-L154.
25. Hartsough MT, Mulder KM,. 1995. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 270: 7117-7124.
26. Hornberg JJ, Binder B, Bruggeman FJ, Schoeberl B, Heinrich R, Westerhoff HV,. 2005. Control of MAPK signalling: From complexity to what really matters. Oncogene 24: 5533-5542.
27. Horne MM, Guadagno TM,. 2003. A requirement for MAP kinase in the assembly and maintenance of the mitotic spindle. J Cell Biol 161: 1021-1028.
28. Iordanskaia T, Nawshad A,. 2011. Mechanisms of transforming growth factor beta induced cell cycle arrest in palate development. J Cell Physiol 226: 1415-1424.
29. Ito Y, Yeo JY, Chytil A, Han J, Bringas P, Jr., Nakajima A, Shuler CF, Moses HL, Chai Y,. 2003. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130: 5269-5280.
30. Izadnegahdar MF, Rathanaswami P, Shah RM,. 1999. Effects of EGF and TGFbeta1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells. Anat Rec 254: 453-464.
31. Jugessur A, Murray JC,. 2005. Orofacial clefting: Recent insights into a complex trait. Curr Opin Genet Dev 15: 270-278.
32. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J,. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11: 415-421.
33. Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF,. 1997. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn 209: 255-260.
34. Khalil N,. 1999. TGF-beta: From latent to active. Microbes Infect 1: 1255-1263.
35. LaGamba D, Nawshad A, Hay ED,. 2005. Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 234: 132-142.
36. Lidral AC, Romitti PA, Basart AM, Doetschman T, Leysens NJ, Daack-Hirsch S, Semina EV, Johnson LR, Machida J, Burds A, Parnell TJ, Rubenstein JL, Murray JC,. 1998. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet 63: 557-568.
37. Lim SK, Hoffmann FM,. 2006. Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-beta signaling. Proc Natl Acad Sci USA 103: 18580-18585.
38. Linask KK, D'Angelo M, Gehris AL, Greene RM,. 1991. Transforming growth factor-beta receptor profiles of human and murine embryonic palate mesenchymal cells. Exp Cell Res 192: 1-9.
39. Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MW,. 2000. Medial edge epithelial cell fate during palatal fusion. Dev Biol 220: 343-357.
40. Massague J, Wotton D,. 2000. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754.
41. Medici D, Nawshad A,. 2010. Type I collagen promotes epithelial- mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol 29: 161-165.
42. Moses HL, Serra R,. 1996. Regulation of differentiation by TGF-beta. Curr Opin Genet Dev 6: 581-586.
43. Moustakas A, Heldin CH,. 2005. Non-Smad TGF-{beta} signals. J Cell Sci 118: 3573-3584.
44. Mu Z, Yang Z, Yu D, Zhao Z, Munger JS,. 2008. TGFbeta1 and TGFbeta3 are partially redundant effectors in brain vascular morphogenesis. Mech Dev 125: 508-516.
45. Mucsi I, Skorecki KL, Goldberg HJ,. 1996. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 271: 16567-16572.
46. Mulder KM,. 2000. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11: 23-35.
47. Nawshad A,. 2008. Palatal seam disintegration: To die or not to die? that is no longer the question. Dev Dyn 237: 2643-2656.
48. Nawshad A, Hay ED,. 2003. TGF{beta}3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol 163: 1291-1301.
49. Nawshad A, LaGamba D, Olsen BR, Hay ED,. 2004. Laser capture microdissection (LCM) for analysis of gene expression in specific tissues during embryonic epithelial-mesenchymal transformation. Dev Dyn 230: 529-534.
50. Nawshad A, Medici D, Liu CC, Hay ED,. 2007. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 120: 1646-1653.
51. Oster SK, Ho CS, Soucie EL, Penn LZ,. 2002. The myc oncogene: MarvelouslY complex. Adv Cancer Res 84: 81-154.
52. Pelengaris S, Khan M,. 2003. The many faces of c-MYC. Arch Biochem Biophys 416: 129-136.
53. Pelton RW, Dickinson ME, Moses HL, Hogan BL,. 1990a. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: Comparative studies with TGF beta 1 and beta 2. Development 110: 609-620.
54. Pelton RW, Hogan BL, Miller DA, Moses HL,. 1990b. Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol 141: 456-460.
55. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T,. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11: 409-414.
56. Roberts AB,. 2002. The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev 13: 3-5.
57. Roberts EC, Hammond K, Traish AM, Resing KA, Ahn NG,. 2006. Identification of G2/M targets for the MAP kinase pathway by functional proteomics. Proteomics 6: 4541-4553.
58. Rubinfeld H, Seger R,. 2005. The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol 31: 151-174.
59. Sherr CJ,. 2000. Cell cycle control and cancer. Harvey Lect 96: 73-92.
60. Shi Y, Massague J,. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
61. Shuler CF, Halpern DE, Guo Y, Sank AC,. 1992. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo. Dev Biol 154: 318-330.
62. Singh G, Singh SK, Konig A, Reutlinger K, Nye MD, Adhikary T, Eilers M, Gress TM, Fernandez-Zapico ME, Ellenrieder V,. 2010. Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation. J Biol Chem 285: 27241-27250.
63. Tsurimoto T,. 1998. PCNA, a multifunctional ring on DNA. Biochim Biophys Acta 1443: 23-39.
64. Vigneron A, Cherier J, Barre B, Gamelin E, Coqueret O,. 2006. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 281: 34742-34750.
65. Wang L, Ma R, Flavell RA, Choi ME,. 2002. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 277: 47257-47262.
66. Yagi K, Furuhashi M, Aoki H, Goto D, Kuwano H, Sugamura K, Miyazono K, Kato M,. 2002. c-myc is a downstream target of the Smad pathway. J Biol Chem 277: 854-861.
67. Yam CH, Fung TK, Poon RY,. 2002. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59: 1317-1326.
68. Yang LT, Kaartinen V,. 2007. Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev Biol 312: 384-395.
69. Yue J, Mulder KM,. 2000. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. J Biol Chem 275: 30765-30773.